Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cystamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 1.00 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 0.91 |
| ▸ | THPO | P40225 | 1/20 | 0.91 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | NOS1 | P29475 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cystamine SCHEMBL196510 | 1.00 | — | — | |
| Cystamine SCHEMBL28842776 | 1.00 | MAPT (1.00) | MAPTTDP1EHMT2TSHRTHPO | |
| Cystamine SCHEMBL28235943 | 1.00 | MAPT (1.00) | MAPTTDP1EHMT2TSHRTHPO | |
| Cystamine SCHEMBL345893 | 1.00 | MAPT (1.00) | MAPTTDP1EHMT2TSHRTHPO | |
| Cystamine SCHEMBL28418529 | 0.96 | MAPT (0.92) | MAPTTDP1EHMT2TSHRTHPO | |
| Cystamine SCHEMBL7903150 | 0.96 | MAPT (0.92) | MAPTTDP1EHMT2TSHRTHPO | |
| Cystamine SCHEMBL28409923 | 0.96 | MAPT (0.92) | MAPTTDP1EHMT2TSHRTHPO | |
| Cystamine SCHEMBL43866 | 0.95 | — | — | |
| Cystamine SCHEMBL3648870 | 0.95 | TSHR (1.00) | MAPTTDP1EHMT2TSHRTHPO | |
| Cystamine SCHEMBL11040994 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3226 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026105108-A2 | AN ERGOTHIONEINE-CURCUMIN SYNERGISTIC ANTI-INFLAMMATORY AND ANTI-AGING COMPLEX COMPOSITION AND A PREPARATION METHOD THEREOF | ZIRAOUI ANAS (EG) | 2026-05-21 | — | — | WO | claimed |
| US-20260139097-A1 | SELF-HEALING MULTI-COMPONENT POLYIMIDE COMPOSITION AND FILM, AND METHOD FOR MANUFACTURING THE SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2026-05-21 | — | — | US | claimed |
| CN-122060219-A | Degradable environment-friendly flame retardant and preparation method thereof | 江西砥石矿纤技术有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122056827-A | Nanometer ophthalmic gel preparation for treating corneal epithelial injury | 福州大学附属省立医院 | 2026-05-19 | — | — | CN | claimed |
| CN-122013511-A | First bath dipping liquid for two-bath dipping method of fiber framework material | 浙江海利得科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122005429-A | Medicine-carrying microneedle patch for inhibiting keloid hyperplasia and preparation method thereof | 中国人民解放军总医院海南医院 | 2026-05-12 | — | — | CN | claimed |
| EP-4678163-A2 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NAIL AND SKIN TINEA | Chang, Byeung Mo (KR) | 2026-01-14 | — | — | EP | claimed |
| CN-118388745-B | Polyurethane elastomer material and preparation method thereof | 菁彩新材料(安徽)有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-120114530-A | Glutaraldehyde gel and preparation method thereof | 沈阳望力生物科技有限公司 | 2025-06-10 | — | — | CN | claimed |
| CN-117428874-B | High-antibacterial mildew-proof composite board for furniture and manufacturing process thereof | 上海拉迷家具有限公司 | 2025-06-03 | — | — | CN | claimed |
| WO-2001084976-A2 | SELF-NEUTRALIZING PERMANENT WAVE COMPOSITION AND METHOD THEREFOR | SHISEIDO CO., LTD. (JP) | 2001-11-15 | — | — | WO | claimed |
| US-6132955-A | Method for derivitizing electrodes and assay methods using such derivitized electrodes | IGEN INTERNATIONAL, INC. (US) | 2000-10-17 | — | — | US | claimed |
| US-6008328-A | PURIFYING PROTEIN BY CATION EXCHANGE RESIN THEN PASSING THROUGH AN MOLECULAR WEIGHT EXCLUSION MATRIX, RECOVERING THE PURIFIED PROTEIN | AMGEN INC. (US) | 1999-12-28 | — | — | US | claimed |
| CN-1034077-C | Process for preparing pyrido [2, 3-f ] [1, 4] thiazepines | ORTHO PHARMA CORP (US) | 1997-02-19 | — | — | CN | claimed |
| WO-1996036870-A1 | METHOD FOR DERIVITIZING ELECTRODES AND ASSAY METHODS USING SUCH DERIVITIZED ELECTRODES | IGEN, INC. (US) | 1996-11-21 | — | — | WO | claimed |
| EP-0462696-B1 | Novel pyrido [2,3-f][1,4] thiazepines and pyrido [3,2-b][1,5] benzothiazepines | ORTHO PHARMA CORP (US) | 1995-08-09 | — | — | EP | claimed |
| EP-0502131-A1 | PRODUCTION OF MULTIMERIC GLYCOPROTEINS THROUGH CHEMICAL COUPLING | BIOGEN, INC. (US) | 1992-09-09 | — | — | EP | claimed |
| WO-1992005188-A1 | PRODUCTION OF MULTIMERIC GLYCOPROTEINS THROUGH CHEMICAL COUPLING | BIOGEN, INC. (US) | 1992-04-02 | — | — | WO | claimed |
| EP-0462696-A1 | Novel pyrido [2,3-f][1,4] thiazepines and pyrido [3,2-b][1,5] benzothiazepines | ORTHO PHARMACEUTICAL CORPORATION (US) | 1991-12-27 | — | — | EP | claimed |
| CN-1056880-A | Novel pyrido [2, 3-f ] [1, 4] thiazepines and pyrido [3, 2-b ] [1, 5] benzothiazepines | ORTHO PHARMA CORP (US) | 1991-12-11 | — | — | CN | claimed |